ATA244484A - Verfahren zur herstellung von hochreinem kristallinem cefuroxim-acetoxyethylester - Google Patents

Verfahren zur herstellung von hochreinem kristallinem cefuroxim-acetoxyethylester

Info

Publication number
ATA244484A
ATA244484A AT842444A AT244484A ATA244484A AT A244484 A ATA244484 A AT A244484A AT 842444 A AT842444 A AT 842444A AT 244484 A AT244484 A AT 244484A AT A244484 A ATA244484 A AT A244484A
Authority
AT
Austria
Prior art keywords
acetoxyethylester
cefuroxim
high purity
producing high
purity crystalline
Prior art date
Application number
AT842444A
Other languages
English (en)
Other versions
AT392470B (de
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ATA244484A publication Critical patent/ATA244484A/de
Application granted granted Critical
Publication of AT392470B publication Critical patent/AT392470B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT2444/84A 1983-07-29 1984-07-27 Verfahren zur herstellung von hochreinem kristallinem cefuroxim-acetoxyethylester AT392470B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838320521A GB8320521D0 (en) 1983-07-29 1983-07-29 Chemical process

Publications (2)

Publication Number Publication Date
ATA244484A true ATA244484A (de) 1990-09-15
AT392470B AT392470B (de) 1991-04-10

Family

ID=10546505

Family Applications (1)

Application Number Title Priority Date Filing Date
AT2444/84A AT392470B (de) 1983-07-29 1984-07-27 Verfahren zur herstellung von hochreinem kristallinem cefuroxim-acetoxyethylester

Country Status (21)

Country Link
JP (1) JPH0613526B2 (de)
KR (1) KR910008377B1 (de)
AT (1) AT392470B (de)
AU (2) AU582121B2 (de)
BE (1) BE900241A (de)
CA (1) CA1265511A (de)
CH (1) CH662121A5 (de)
DE (1) DE3427828A1 (de)
DK (1) DK165505C (de)
ES (1) ES534695A0 (de)
FI (1) FI76808C (de)
FR (1) FR2549837B1 (de)
GB (2) GB8320521D0 (de)
IE (1) IE57726B1 (de)
IL (1) IL72536A (de)
NL (1) NL8402372A (de)
NO (1) NO167292C (de)
NZ (1) NZ209046A (de)
PT (1) PT78985B (de)
SE (1) SE463263B (de)
ZA (1) ZA845830B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
IT1277426B1 (it) * 1995-08-03 1997-11-10 Acs Dobfar Spa Forma cristallina biodisponibile del cefuroxima axetil
CN1111537C (zh) * 1997-05-15 2003-06-18 第一制糖株式会社 高纯晶形头孢呋辛1－乙酰氧乙酯的制备方法
KR100228264B1 (ko) * 1997-08-02 1999-11-01 김선진 결정형 세푸록심 악세틸의 제조방법
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B (de) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
ES2171056T3 (es) * 1998-02-20 2002-08-16 Fako Ilaclari A S Procedimiento para la fabricacion de cefuroxima axetil cristalina soluble.
IN190849B (de) 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
AT411996B (de) 2000-09-11 2004-08-26 Sandoz Ag Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes
ITMI20011763A1 (it) * 2001-08-10 2003-02-10 Antibioticos Spa Processo di preparazione di cefuroxime axelite ad elevata purezza
ITMI20011925A1 (it) * 2001-09-14 2003-03-14 Antibioticos Spa Metodo applicabile su scala industriale per la preparazione di cefuroxime axetile cristallino
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
CN100448879C (zh) * 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
CN118561870A (zh) * 2024-05-15 2024-08-30 广东立国制药有限公司 一种制备头孢呋辛酸的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
JPS577485A (en) * 1980-06-13 1982-01-14 Takeda Chem Ind Ltd Cephalosporin
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics

Also Published As

Publication number Publication date
NZ209046A (en) 1988-02-29
DK165505B (da) 1992-12-07
FI843011A0 (fi) 1984-07-27
FR2549837A1 (fr) 1985-02-01
GB8320521D0 (en) 1983-09-01
CH662121A5 (de) 1987-09-15
IL72536A0 (en) 1984-11-30
SE8403897L (sv) 1985-01-30
DK165505C (da) 1993-04-19
BE900241A (fr) 1985-01-28
SE463263B (sv) 1990-10-29
ZA845830B (en) 1986-03-26
AU3125684A (en) 1985-01-31
PT78985A (en) 1984-08-01
NO843055L (no) 1985-01-30
DK366684D0 (da) 1984-07-27
DK366684A (da) 1985-01-30
ES8601869A1 (es) 1985-11-01
NL8402372A (nl) 1985-02-18
NO167292C (no) 1991-10-23
IE841938L (en) 1985-01-29
AU582121B2 (en) 1989-03-16
GB2145409B (en) 1987-02-18
FR2549837B1 (fr) 1986-12-26
KR850001221A (ko) 1985-03-16
AU634965B2 (en) 1993-03-11
SE8403897D0 (sv) 1984-07-27
FI76808C (fi) 1988-12-12
PT78985B (en) 1986-10-23
KR910008377B1 (ko) 1991-10-12
AT392470B (de) 1991-04-10
GB2145409A (en) 1985-03-27
CA1265511A (en) 1990-02-06
JPS6075484A (ja) 1985-04-27
DE3427828A1 (de) 1985-02-14
FI76808B (fi) 1988-08-31
JPH0613526B2 (ja) 1994-02-23
AU3660189A (en) 1989-10-05
IL72536A (en) 1988-01-31
ES534695A0 (es) 1985-11-01
NO167292B (no) 1991-07-15
GB8419202D0 (en) 1984-08-30
IE57726B1 (en) 1993-03-24
FI843011L (fi) 1985-01-30

Similar Documents

Publication Publication Date Title
DE3578604D1 (de) Verfahren zur herstellung von kristallinen natriumsilikaten.
AT386205B (de) Verfahren zur herstellung von hochreinem natrium-cefuroxim
AT383808B (de) Verfahren zur herstellung von penemen
ATA244484A (de) Verfahren zur herstellung von hochreinem kristallinem cefuroxim-acetoxyethylester
ATA423783A (de) Verfahren zur herstellung von beta-hydroxybuttersaeurederivaten
ATA224084A (de) Verfahren zur herstellung von alkoholen
AT379831B (de) Verfahren zur herstellung von kristallen
ATA199684A (de) Verfahren zur herstellung von 6-deoxyanthracyclinonen
AT387024B (de) Verfahren zur herstellung von aspartam
AT388917B (de) Verfahren zur herstellung von pyrimidintrionderivaten
ATA278885A (de) Verfahren zur herstellung von cephalosporinderivaten
ATA178085A (de) Verfahren zur herstellung von 1-thiosubstituierten n-methyl-2-nitroaethenaminen
AT384024B (de) Verfahren zur herstellung von azinomethylrifamycinen
ATA252985A (de) Verfahren zur herstellung von
ATA319282A (de) Verfahren zur herstellung von reinem 3-amino-crotonitril
ATA118683A (de) Verfharen zur herstellung von 1-naphthol-4-sulfonsaeure (nevile-winther-saeure)
AT379814B (de) Verfahren zur herstellung von hochreinem tricyclohexylzinnhydroxid
AT387386B (de) Verfahren zur herstellung von kondensierten as-triazin-derivaten
AT381723B (de) Verfahren zur herstellung von cephalosporin c
AT386411B (de) Verfahren zur herstellung von neuem kristallinem 7-d-alpha-amino-alpha-(3-chlor-4-hydroxyphenyl) acetamido)-3-methyl-3-cephem-4-carbonsaeuremonohydrat
ATA130484A (de) Verfahren zur herstellung von iminodibenzyl
ATA337083A (de) Verfahren zur herstellung von monoalkalisalzen von 7-amino-3-cephem-4-carbonsaeurederivaten
ATA119884A (de) Verfahren zur herstellung von cephalosporinantibiotika
ATA105584A (de) Verfahren zur herstellung von cephalosporinderivaten
ATA3284A (de) Verfahren zur herstellung von mercaptoacyl-lprolinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee